A quick peek into the report
Table of Contents
1.1 Industry Outlook
1.1.1 Market Overview
1.1.2 Epidemiological Analysis of Burns
1.1.2.1 By Region
1.1.3 Regulatory Landscape of Global Burns Market
1.1.3.1 Legal Requirement and Framework in the U.S.
1.1.3.2 Legal Requirement and Framework in the E.U.
1.1.3.3 Legal Requirement and Framework in Japan
1.1.3.4 Legal Requirement and Framework in Rest-of-the-World
1.1.4 Key Trends
1.1.5 Clinical Trial Analysis
1.2 Market Dynamics
1.2.1 Impact Analysis
1.2.2 Market Drivers
1.2.3 Market Restraint
1.2.4 Market Opportunities
2.1 Overview
2.2 Drugs
2.2.1 Analgesics
2.2.2 Topical Antimicrobials
2.2.3 Antibiotics
2.2.4 Others
2.3 Advanced Dressings
2.4 Biologics
2.5 Traditional Burn Care Products
2.6 Others
3.1 Overview
3.2 First-degree burn
3.3 Second-degree burn
3.4 Third-degree burn
3.5 Fourth-degree burn
4.1 North America
4.1.1 Key Market Participants in North America
4.1.2 Business Drivers
4.1.3 Business Challenges
4.1.4 Market Sizing and Forecast
4.1.4.1 North America Burns Market, by Country
4.1.4.1.1 U.S.
4.1.4.1.2 Canada
4.2 Europe
4.2.1 Key Market Participants in Europe
4.2.2 Business Drivers
4.2.3 Business Challenges
4.2.4 Market Sizing and Forecast
4.2.4.1 Europe Burns Market, by Country
4.2.4.1.1 Germany
4.2.4.1.2 U.K.
4.2.4.1.3 France
4.2.4.1.4 Italy
4.2.4.1.5 Spain
4.2.4.1.6 Rest-of -Europe
4.3 Asia-Pacific
4.3.1 Key Market Participants in Asia-Pacific
4.3.2 Business Drivers
4.3.3 Business Challenges
4.3.4 Market Sizing and Forecast
4.3.4.1 Asia-Pacific Burns Market, by Country
4.3.4.1.1 Japan
4.3.4.1.2 China
4.3.4.1.3 India
4.3.4.1.4 Rest-of-Asia-Pacific
4.4 Rest-of-the-world
4.4.1 Key Market Participants in Rest-of-the-world
4.4.2 Business Drivers
4.4.3 Business Challenges
4.4.4 Market Sizing and Forecast
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Key Developments and Strategies
5.1.2.1 Funding Activities
5.1.2.2 Mergers and Acquisitions
5.1.2.3 Regulatory Approvals
5.1.2.4 Partnerships, Collaborations and Business Expansions
5.1.3 Growth-Share Analysis (by Company)
5.2 Company Profiles
5.2.1 Pfizer
5.2.1.1 Overview
5.2.1.2 Product Portfolio
5.2.1.3 Target Customers
5.2.1.4 Key Professionals
5.2.1.5 Analyst View
5.2.2 Perrigo Company plc
5.2.2.1 Overview
5.2.2.2 Product Portfolio
5.2.2.3 Target Customers
5.2.2.4 Key Professionals
5.2.2.5 Analyst View
5.2.3 Kenvue Brands LLC
5.2.3.1 Overview
5.2.3.2 Product Portfolio
5.2.3.3 Target Customers
5.2.3.4 Key Professionals
5.2.3.5 Analyst View
5.2.4 3M
5.2.4.1 Overview
5.2.4.2 Product Portfolio
5.2.4.3 Target Customers
5.2.4.4 Key Professionals
5.2.4.5 Analyst View
5.2.5 Smith+Nephew
5.2.5.1 Overview
5.2.5.2 Product Portfolio
5.2.5.3 Target Customers
5.2.5.4 Key Professionals
5.2.5.5 Analyst View
5.2.6 Mölnlycke Health Care AB.
5.2.6.1 Overview
5.2.6.2 Product Portfolio
5.2.6.3 Target Customers
5.2.6.4 Key Professionals
5.2.6.5 Analyst View
5.2.7 Car?dinal Health
5.2.7.1 Overview
5.2.7.2 Product Portfolio
5.2.7.3 Target Customers
5.2.7.4 Key Professionals
5.2.7.5 Analyst View
5.2.8 Convatec Inc
5.2.8.1 Overview
5.2.8.2 Product Portfolio
5.2.8.3 Target Customers
5.2.8.4 Key Professionals
5.2.8.5 Analyst View
5.2.9 Haleon Group of Companies
5.2.9.1 Overview
5.2.9.2 Product Portfolio
5.2.9.3 Target Customers
5.2.9.4 Key Professionals
5.2.9.5 Analyst View
5.2.10 Coloplast
5.2.10.1 Overview
5.2.10.2 Product Portfolio
5.2.10.3 Target Customers
5.2.10.4 Key Professionals
5.2.10.5 Analyst View
5.2.11 DeRoyal Industries, Inc
5.2.11.1 Overview
5.2.11.2 Product Portfolio
5.2.11.3 Target Customers
5.2.11.4 Key Professionals
5.2.11.5 Analyst View
5.2.12 Others
Research Methodology
Table: Global Burns Market, Regulatory Scenario
Table: Global Burns Market Dynamics, Impact Analysis
Figure: Global Burns Market, Market Overview
Figure: Global Burns Market, Epidemiological Analysis,
Figure: Global Burns Market Coverage
Figure: Global Burns Market Key Trends, Impact Analysis, 2023-2035
Figure: Global Burns Market, Competitive Landscape, January 2022-April 2025
Burns Market Report Coverage
|
Burns Market |
|||
|
Base Year |
2024 |
Market Size in 2024 |
$XX Billion |
|
Forecast Period |
2025-2035 |
Value Projection and Estimation by 2035 |
$XX Billion |
|
CAGR During Forecast Period |
XX% |
|
|
Some of the prominent names established in this market are:
• Pfizer
• Perrigo Company plc
• Kenvue Brands LLC
• 3M
• Smith+Nephew
• Mölnlycke Health Care AB
• Cardinal Health
• Convatec Inc
• Haleon Group of Companies
• Coloplast
• DeRoyal Industries, Inc
How can this report add value to an organization?
Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in burns market, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.
Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.
Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors’ strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.
Investment and Business Expansion Strategy: By analyzing market trends, funding patterns, and partnership opportunities, the report assists organizations in making informed investment decisions and identifying potential M&A opportunities for business growth.
Global Burns Market, Analysis and Forecast: 2025-2035
The global burns market is witnessing significant growth, driven by rising incidences of thermal, chemical, and electrical burns, increasing awareness about wound care, and the introduction of advanced treatment solutions. Burn injuries remain a substantial public health concern globally, especially in low- and middle-income countries, leading to rising demand for comprehensive treatment solutions, ranging from pain management to surgical interventions and biologic therapies.
Growth in the burns market is being propelled by increasing road accidents, domestic fire incidents, and industrial mishaps, along with expanding healthcare infrastructure and public health initiatives. Key components of burn treatment include pharmacological therapies such as analgesics, topical antimicrobials, and antibiotics, as well as non-pharmacological interventions like advanced wound dressings, surgical debridement, and biologic skin substitutes. Innovations in bioengineered skin, regenerative therapies, and drug delivery systems are expanding the clinical arsenal available to burn care providers.
The market is witnessing rapid adoption of advanced wound care products, such as hydrogel, foam, and silver-impregnated dressings, due to their ability to manage moisture balance, prevent infection, and accelerate healing. Biologic skin grafts, both allografts and autografts, are also gaining traction, particularly in treating full-thickness burns. Moreover, supportive therapies such as nutritional support and psychological counselling are increasingly recognized as essential components of holistic burn recovery.
Despite promising growth, the burns market faces constraints such as the high cost of biologics, limited access to specialized burn centres in developing countries, and inconsistent reimbursement policies. The efficacy of treatment also varies based on burn severity and timing of medical intervention, posing challenges to outcome standardization.
Key market players are investing in R&D to introduce more effective and patient-friendly solutions, including spray-on skin technologies and stem cell-based therapies. Strategic partnerships, government initiatives, and public-private collaborations are further enhancing the reach and impact of burn care solutions. Increasing implementation of digital wound assessment tools and telemedicine platforms is expected to improve early diagnosis and long-term monitoring.
Looking ahead, the global burns market is expected to maintain a steady growth trajectory driven by innovation, increased trauma awareness, and expanding access to modern healthcare. The integration of regenerative medicine, precision therapies, and digital health platforms will be pivotal in redefining patient outcomes and optimizing burn care delivery across both high- and low-resource settings.
Market Segmentation:
Segmentation 1: by Product Type
• Drugs
• Advance Dressings
• Biologics
• Traditional Burn Care Products
• Others
Segmentation 2: by Burn Type
• First degree burn
• Second degree burn
• Third degree burn
• Fourth degree burn
Segmentation 3: by Region
• North America
• Europe
• Asia-Pacific
• Rest-of-the-world
The burns market will continue to evolve with a focus on enhancing therapeutic efficacy, reducing recovery time, and expanding access to care. Emphasis on personalized treatment regimens and integrated care delivery will be central to improving patient outcomes and reducing the global burden of burns.
Global Burns Market
Focus on Product Type, Burn Type, and Country Analysis - Analysis and Forecast, 2025-2035
This report will be delivered in 7-10 working days.
Frequently Asked Questions
The global burns market is led by prominent companies such as Smith + Nephew, 3M, Mölnlycke Health Care, Convatec Inc, and Coloplast.
Trends:
• Adoption of advanced wound care products (silver, hydrogel, and foam dressings)
• Introduction of regenerative medicine and stem-cell therapies
• Use of digital tools and AI for wound monitoring and management
Driver:
• Rising incidence of burn injuries due to accidents and occupational hazards
• Increasing public and private investment in healthcare infrastructure
• Technological advancements in biologics and tissue engineering
• High treatment costs, particularly for biologics and surgeries
• Limited availability of specialized burn care facilities in low-income regions
• Variable insurance coverage and reimbursement issues
• Development of portable and telemedicine-supported burn care tools
• Integration of personalized regenerative therapies
• Expanding access through global health partnerships and public awareness campaigns